Recent highlights of Sullivan & Cromwell's Middle East M&A and joint venture work include representing:
  • Teva Pharmaceutical in its $40.5 billion acquisition of Allergan Generics and its $50.5 billion unsolicited proposal for Mylan, later terminated.
     
  • Goldman Sachs, in its strategic cooperation arrangements with, and equity investment in, NCB Capital, the investment banking subsidiary of the National Commercial Bank of Saudi Arabia.
     
  • Abu Dhabi Future Energy, in its investment in WinWinD Oy, a wind turbines manufacturer.
     
  • AT&T, in connection with a mobile license bid in Qatar and in a confidential matter in the Gulf.
     
  • BP, as global coordinating counsel, in the $7 billion sale of its upstream assets in the United States, Canada and Egypt to Apache.
     
  • a financial institution, in a confidential joint venture arrangement in Saudi Arabia.
     
  • Mubadala Development, on European Commission competition matters, in its $8 billion commercial finance joint venture with General Electric.
     
  • DP World, in its sale of 100 percent of the outstanding stock of P&O Ports North America and PORTS Insurance to AIG Global Investment Group's infrastructure fund.
     
  • DP World, in the acquisition of the international terminals and port logistics business, primarily located in Hong Kong, China and Korea, from CSX.
     
  • an oil company controlled by a leading Saudi merchant family, in several M&A transactions.
     
  • a major Egyptian company, in connection with a multibillion dollar merger and another Egyptian company in connection with a multibillion dollar acquisition.
     
  • an Egyptian company, on the restructuring of a significant joint venture.